(Total Views: 64)
Posted On: 10/26/2023 10:30:48 AM
Post# of 85477
$MBIO News Article - Mustang Bio Announces FDA Acceptance of IND Application for MB-109, a Novel Combination of MB-101 (IL13R?2-targeted CAR-T cell therapy) and MB-108 (HSV-1 oncolytic virus), for the Treatment of Recurrent Glioblastoma and High-Grade Astrocytoma https://marketwirenews.com/news-releases/must...52802.html
(0)
(0)
My Twitter: WhyteStocks
